omega-n-methylarginine has been researched along with s-nitrosopenicillamine in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (s-nitrosopenicillamine) | Trials (s-nitrosopenicillamine) | Recent Studies (post-2010) (s-nitrosopenicillamine) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 19 | 0 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akahori, M; Takeyama, N; Tanaka, T; Yamada, S | 1 |
1 other study(ies) available for omega-n-methylarginine and s-nitrosopenicillamine
| Article | Year |
|---|---|
Nitric oxide ameliorates actinomycin D/endotoxin-induced apoptotic liver failure in mice.
Topics: Aminoquinolines; Animals; Apoptosis; Dactinomycin; Dibutyryl Cyclic GMP; DNA Fragmentation; Hepatic Encephalopathy; Hydroxylamine; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred ICR; Mice, Mutant Strains; Microscopy, Confocal; Nitrates; Nitric Oxide; Nitrites; Nitroso Compounds; omega-N-Methylarginine | 1999 |